TWST Twist Bioscience Corporation
Health Care, filed as Twist Bioscience Corp (COMMON STOCK), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
Bought by 2 managers in 2026 Q3, sold by 1
In 2026 Q3 Henry Ellenbogen opened a position in Twist Bioscience, Polen Capital Management added, and Cathie Wood trimmed.
Who owns this now
Largest portfolio weights among holders, up to 3.8% (Cathie Wood, ARK Investment Management). Not free-float ownership.
Who owns TWST
Sorted by value, long equity only, as of 2026 Q3.
| History | |||||
|---|---|---|---|---|---|
| Cathie Wood, ARK Investment Management | Reduce −25.3% | 3,398,057 | $657M | History | |
| Farallon Capital Management | Hold | 2,136,400 | $413M | History | |
| Henry Ellenbogen, Durable Capital Partners | New 0.50% | 251,000 | $49M | History | |
| Polen Capital Management | Add +46.9% | 81,226 | $16M | History |
Insider trades
Open-market buys and sales by TWST's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $5.6M sold by 3 insiders outside a trading plan
- $112M sold by 6 insiders under 10b5-1 plans
-
Paula Green SVP of Human ResourcesSale— 20,429 shares 14% of stakeTraded Nov 12 Filed Nov 16
-
Emily M. Leproust CEOPlanned sale$919K 4,548 shares at $202.15 0.8% of stakeTraded Oct 5 Filed Oct 7
-
Emily M. Leproust CEOPlanned sale$131K 655 shares at $200.00 0.1% of stakeTraded Oct 1 Filed Oct 5
-
Emily M. Leproust CEOPlanned sale$923K 5,203 shares at $177.38 0.8% of stakeTraded Sep 24 Filed Sep 25
-
Emily M. Leproust CEOPlanned sale$56.3M 356,546 shares at $157.99 37% of stakeTraded Sep 17 Filed Sep 21
-
Emily M. Leproust CEOPlanned sale$6.3M 41,570 shares at $151.98 5.1% of stakeTraded Aug 25 Filed Aug 27
-
Dennis Cho See RemarksPlanned sale$1.8M 14,205 shares at $129.75 16% of stakeTraded Aug 19 Filed Aug 21
-
Patrick John Finn COOPlanned sale$9.2M 78,355 shares at $117.64 27% of stakeTraded Aug 18 Filed Aug 20
-
Emily M. Leproust CEOPlanned sale$2.5M 19,952 shares at $125.08 2.4% of stakeTraded Aug 12 Filed Aug 14
-
Emily M. Leproust CEOPlanned sale$14.2M 113,318 shares at $125.16 12% of stakeTraded Aug 10 Filed Aug 12
-
Robert Chess DirectorPlanned sale$2M 18,417 shares at $110.89 47% of stakeTraded Aug 7 Filed Aug 11
-
Dennis Cho See RemarksPlanned sale$1.6M 14,205 shares at $109.75 14% of stakeTraded Aug 5 Filed Aug 7
-
Emily M. Leproust CEOPlanned sale$1.8M 18,880 shares at $95.00 2.2% of stakeTraded Jun 25 Filed Jun 26
-
Dennis Cho See RemarksPlanned sale$1.3M 14,205 shares at $89.75 12% of stakeTraded Jun 24 Filed Jun 26
-
Paula Green SVP of Human ResourcesSale$2.1M 26,137 shares at $81.67 18% of stakeTraded Jun 15 Filed Jun 17
Also filed in the last 12 months, not counted as buying or selling: 92 sales to cover taxes, 21 option exercises, 18 stock grants, and 2 gifts.
SEC filings
Recent issuer filings from EDGAR, 6 shown.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Total current assets | $424.26M | $346.78M | $332.97M | $737.22M |
| Total non-current assets * | $352.15M | $267.55M | $308.9M | $384.58M |
| Total assets | $0.776B | $0.614B | $0.642B | $1.12B |
| Total current liabilities | $73.32M | $71.01M | $91.41M | $125.81M |
| Total non-current liabilities * | $79.65M | $70.63M | $77.5M | $107.98M |
| Total equity | $623.43M | $472.69M | $472.96M | $888.02M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon